Topical Rx therapies alone may not provide adequate control for many
    patients with moderate-to-severe atopic dermatitis (AD)
    
    The following may indicate that your patient is appropriate for DUPIXENT:
- Have tried a variety of topical prescription therapies for moderate-to-severe atopic dermatitis and are still uncontrolled1
- Suffer from inadequate control of pruritus1
- Have moderate-to-severe erythema and moderate-to-severe papulation/infiltration (IGA 3 or 4)2
- Have ≥10% of their body covered with lesions3
- Have disease that may involve problem areas, such as the face, hands, and feet3
- Initially had itch and 
 hyperpigmentation on arms, back,
 and chest
- Saw multiple providers who each 
 prescribed medium-potency TCS
- Consulted a specialist after 7 years
- Completed 3 rounds of high-potency 
 TCS in past year
- Hyperpigmented papules, patches, 
 and plaques across back and arms
- Frustrated by frequent TCS 
 application, describing it as
 “cumbersome” and “uncomfortable”
Real image of uncontrolled moderate-to-severe atopic dermatitis. 
Story inspired by people who suffer from atopic dermatitis. 
- Legs and arms affected by itch 
 and lesions
- PCP prescribed medium-potency TCS
- Consulted specialist after 2 years of 
 inadequate control
- Almost daily application of medium-
 potency TCS for past 6 months
- Itchy every day and night; patient 
 says, “it's just my normal”
- Enjoys sports, but the uniforms 
 exacerbate her itch
- Fidgety and distracted during 
 office visits
Real image of uncontrolled moderate-to-severe atopic dermatitis. 
Story inspired by people who suffer from atopic dermatitis. 
- Dry patches and lichenification 
 developed on arms and torso, along
 with itch
- PCP prescribed medium-potency 
 TCS, which failed to fully resolve
 lesions
- Consulted specialist after 1 year
- Primarily using high-potency TCS for 
 the past 6 months
- Stepping down to medium-potency 
 TCS hasn't been successful
- Always wears long sleeves and 
 pants to cover up, but is “used to it”
Real image of uncontrolled moderate-to-severe atopic dermatitis. 
Story inspired by people who suffer from atopic dermatitis. 
For your patients aged 6+ months with moderate-to-severe AD
 uncontrolled with topical Rx therapy, ask yourself:
If you answer “Yes” to either of these questions,
THEY MAY BE DU FOR DUPIXENT
IGA, Investigator’s Global Assessment; PCP, primary care physician; TCS, topical corticosteroids.
Real Providers share real patient stories